Dr. Reddy's Laboratories Ltd. ADR Stock
There is no change in the price for Dr. Reddy's Laboratories Ltd. ADR today.
The community is currently still undecided about Dr. Reddy's Laboratories Ltd. ADR with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 14 € shows a positive potential of 25.0% compared to the current price of 11.2 € for Dr. Reddy's Laboratories Ltd. ADR.
Criterium "Brand" is seen as the biggest plus for Dr. Reddy's Laboratories Ltd. ADR stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Dr. Reddy's Laboratories Ltd. ADR in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dr. Reddy's Laboratories Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 0.000% | -1.754% | -8.197% | -0.885% | -4.274% | -79.065% | -78.462% |
| Sihuan Pharmaceutical Holdings Group Ltd. | -0.660% | -0.658% | -3.822% | 122.059% | 15.267% | 61.497% | -33.772% |
| Recordati SpA | -0.700% | -2.236% | 8.219% | 3.159% | 0.823% | 22.573% | 7.412% |
| Swedish Orphan Biovitrum Ab | 2.260% | 1.829% | 10.122% | 63.896% | 23.242% | 59.882% | 171.983% |
Comments
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target lowered by analysts at Barclays PLC from $17.40 to $17.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for RDY provided by MarketBeat